Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 76 AL 90

Exploring new avenues for modifying course of progression of Alzheimer's disease: The rise of natural medicine

Lye S, Aust CE, Griffiths LR, Fernandez F.

J Neurol Sci. 2021 Mar 15;422:117332. doi: 10.1016/j.jns.2021.117332. Epub 2021 Jan 30.

Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer's disease neuropathology

Hossain MF, Wang N, Chen R, Li S, Roy J, Uddin MG, Li Z, Lim LW, Song YQ.

Ageing Res Rev. 2021 May;67:101304. doi: 10.1016/j.arr.2021.101304. Epub 2021 Feb 18.

Role of Hypoxia Inducible Factor-1α in Alzheimer's Disease

Wang YY, Huang ZT, Yuan MH, Jing F, Cai RL, Zou Q, Pu YS, Wang SY, Chen F, Yi WM, Zhang HJ, Cai ZY.

J Alzheimers Dis. 2021;80(3):949-961. doi: 10.3233/JAD-201448.

Neuroinflammation in Alzheimer's disease and beneficial action of luteolin

Delgado A, Cholevas C, Theoharides TC.

Biofactors. 2021 Mar;47(2):207-217. doi: 10.1002/biof.1714. Epub 2021 Feb 21.

Re-emphasizing early Alzheimer's disease pathology starting in select entorhinal neurons, with a special focus on mitophagy

Kobro-Flatmoen A, Lagartos-Donate MJ, Aman Y, Edison P, Witter MP, Fang EF.

Ageing Res Rev. 2021 May;67:101307. doi: 10.1016/j.arr.2021.101307. Epub 2021 Feb 20.

Intranasal drug delivery for treatment of Alzheimer's disease

Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, Fonte P.

Drug Deliv Transl Res. 2021 Apr;11(2):411-425. doi: 10.1007/s13346-021-00940-7. Epub 2021 Feb 26.

APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention

Zhou X, Fu AK, Ip NY.

Curr Opin Neurobiol. 2021 Aug;69:58-67. doi: 10.1016/j.conb.2021.02.001. Epub 2021 Feb 26.

Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer' s disease

Wang Z, Sun H, Zhang Q, Yang J, Liu Y, Liu H, Shi C, Wang Y, Xu Y.

Stem Cell Res. 2021 May;53:102267. doi: 10.1016/j.scr.2021.102267. Epub 2021 Feb 24.

Natural Products Targeting Amyloid Beta in Alzheimer's Disease

Lee JH, Ahn NH, Choi SB, Kwon Y, Yang SH.

Int J Mol Sci. 2021 Feb 26;22(5):2341. doi: 10.3390/ijms22052341.

Accelerating Alzheimer's disease drug discovery and development: what's the way forward?

Imbimbo BP, Ippati S, Watling M, Balducci C.

Expert Opin Drug Discov. 2021 Jul;16(7):727-735. doi: 10.1080/17460441.2021.1887132. Epub 2021 Mar 2.

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease

Singh YP, Rai H, Singh G, Singh GK, Mishra S, Kumar S, Srikrishna S, Modi G.

Eur J Med Chem. 2021 Apr 5;215:113278. doi: 10.1016/j.ejmech.2021.113278. Epub 2021 Feb 15.

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy

Arya A, Chahal R, Rao R, Rahman MH, Kaushik D, Akhtar MF, Saleem A, Khalifa SMA, El-Seedi HR, Kamel M, Albadrani GM, Abdel-Daim MM, Mittal V.

Biomolecules. 2021 Feb 25;11(3):350. doi: 10.3390/biom11030350.

The Neurovascular Unit Dysfunction in Alzheimer's Disease

Soto-Rojas LO, Pacheco-Herrero M, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Villegas-Rojas MM, Harrington CR, de la Cruz F, Garcés-Ramírez L, Luna-Muñoz J.

Int J Mol Sci. 2021 Feb 18;22(4):2022. doi: 10.3390/ijms22042022.

Value-Generating Exploratory Trials in Neurodegenerative Dementias

Friedman LG, McKeehan N, Hara Y, Cummings JL, Matthews DC, Zhu J, Mohs RC, Wang D, Hendrix SB, Quintana M, Schneider LS, Grundman M, Dickson SP, Feldman HH, Jaeger J, Finger EC, Ryan JM, Niehoff D, Dickinson SL, Markowitz JT, Owen M, Travaglia A, Fillit HM.

Neurology. 2021 May 18;96(20):944-954. doi: 10.1212/WNL.0000000000011774. Epub 2021 Mar 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias